Laparoscopic gastrectomy and impact on recurrence of gastric cancer

[1] Jeong SH(2011)Risk of recurrence after laparoscopy-assisted radical gastrectomy for gastric cancer performed by a single surgeon Surg Endosc 25 872-878

[2] Lee YJ(2010)Complete genome sequencing and network modeling to overcome trastuzumab resistance Pharmacogenomics 11 1039-1043

[3] Park ST(2011)Measurable evidence of miRNAs as regulators of cancer networks and therapeutic targets Expert Rev Med Devices 8 123-126

[4] Choi SK(2002)Targeting the optimal extent of lymph node dissection for gastric cancer J Surg Oncol 81 59-62

[5] Hong SC(2004)Is it time to change surgical strategy for gastric cancer in the United States? Ann Surg Oncol 11 727-730

[6] Jung EJ(1998)Extended lymphadenectomy in gastric cancer: when, for whom and why Ann R Coll Surg Engl 80 16-24

[7] Joo YT(2000)Extended (D2) lymph node dissection for gastric cancer: do patients benefit? Ann Surg Oncol 7 253-255

[8] Jeong CY(2007)Level I evidence in support of perioperative chemotherapy for operable gastric cancer: sufficient for wide clinical use? Ann Surg Oncol 14 2691-2695

[9] Ha WS(2011)Trastuzumab and beyond: sequencing cancer genomes and predicting molecular networks Pharmacogenomics J 11 81-92

[10] Roukos DH(2011)Cancer genome explosion and systems biology: impact on surgical oncology? Ann Surg Oncol 18 12-15

[1] Jeong SH(2011)Risk of recurrence after laparoscopy-assisted radical gastrectomy for gastric cancer performed by a single surgeon Surg Endosc 25 872-878

[2] Lee YJ(2010)Complete genome sequencing and network modeling to overcome trastuzumab resistance Pharmacogenomics 11 1039-1043

[3] Park ST(2011)Measurable evidence of miRNAs as regulators of cancer networks and therapeutic targets Expert Rev Med Devices 8 123-126

[4] Choi SK(2002)Targeting the optimal extent of lymph node dissection for gastric cancer J Surg Oncol 81 59-62

[5] Hong SC(2004)Is it time to change surgical strategy for gastric cancer in the United States? Ann Surg Oncol 11 727-730

[6] Jung EJ(1998)Extended lymphadenectomy in gastric cancer: when, for whom and why Ann R Coll Surg Engl 80 16-24

[7] Joo YT(2000)Extended (D2) lymph node dissection for gastric cancer: do patients benefit? Ann Surg Oncol 7 253-255

[8] Jeong CY(2007)Level I evidence in support of perioperative chemotherapy for operable gastric cancer: sufficient for wide clinical use? Ann Surg Oncol 14 2691-2695

[9] Ha WS(2011)Trastuzumab and beyond: sequencing cancer genomes and predicting molecular networks Pharmacogenomics J 11 81-92

[10] Roukos DH(2011)Cancer genome explosion and systems biology: impact on surgical oncology? Ann Surg Oncol 18 12-15